Lateral flow assays (LFAs), such as the COVID-19 rapid test, are powerful devices to rapidly detect a protein’s presence or absence. This assay is so easy to perform that it enables at-home testing, ...

Lateral flow assay applications have become increasingly diverse in a post-pandemic world, and the areas of infectious disease and oncology continue to be at the forefront. In both areas, the use of ...

In today’s evolving diagnostic landscape, limitations in assay sensitivity and stability can quickly become barriers to reliable at-home testing. Developers and manufacturers must balance performance, ...

In our best practices blog, we explore how lateral flow assay design affects test performance. Read on to gain a deeper understanding of the development process, enabling you to streamline the ...

Following the beginning of the COVID-19 outbreak, lateral flow assays (LFAs)—the category of test strips in which the ...

The rapid global outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused the coronavirus disease 2019 (COVID-19) pandemic, which has claimed more ...

"Lateral Flow Assays Market by Product (Kits, Readers), Application (STI, HEP, TB, Cardiac Marker, Pregnancy, Drug Abuse, Food Safety), Sample (Blood, Urine, Saliva ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.